These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17902224)

  • 41. Understanding the costs of pharmaceuticals.
    Valenti WM
    AIDS Read; 2004 Sep; 14(9):467-8, 471. PubMed ID: 15457597
    [No Abstract]   [Full Text] [Related]  

  • 42. South Africa cuts agreement for one AIDS drug but ignores another.
    IAPAC Mon; 2001 Feb; 7(2):41. PubMed ID: 11302027
    [No Abstract]   [Full Text] [Related]  

  • 43. Abbott Laboratories' pricing malfunction.
    Salyer D
    Surviv News (Atlanta Ga); 2004; 15(3):18-9. PubMed ID: 15218860
    [No Abstract]   [Full Text] [Related]  

  • 44. European license for Viracept re-established by EC.
    AIDS Patient Care STDS; 2007 Nov; 21(11):891. PubMed ID: 18338433
    [No Abstract]   [Full Text] [Related]  

  • 45. Abbott announces RTV price concessions.
    Alcorn K
    IAPAC Mon; 2004 Mar; 10(3):77. PubMed ID: 15108678
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug pricing. AHF presses for indemnification over Norvir price increase.
    AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045980
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug pricing. HIV/AIDS patients file federal antitrust suit against Abbott.
    AIDS Policy Law; 2004 May; 19(9):9. PubMed ID: 15202406
    [No Abstract]   [Full Text] [Related]  

  • 48. Study: disparity between rich and poor mortality.
    AIDS Alert; 2003 Aug; 18(8):97-8, 103. PubMed ID: 12921057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A tragic and lucrative growth industry.
    Bateman C
    S Afr Med J; 2002 Jan; 92(1):17-8. PubMed ID: 11936003
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccines and medicines for the world's poorest. Attempts of global forum for health research should be viewed with optimistic scepticism.
    MacDonald R
    BMJ; 2000 Sep; 321(7264):834. PubMed ID: 11009544
    [No Abstract]   [Full Text] [Related]  

  • 51. AIDS and the private sector.
    Nature; 2006 Oct; 443(7113):723. PubMed ID: 17051166
    [No Abstract]   [Full Text] [Related]  

  • 52. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir.
    Huff B
    GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438
    [No Abstract]   [Full Text] [Related]  

  • 53. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 54. Controversy over ritonavir price increase.
    AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032179
    [No Abstract]   [Full Text] [Related]  

  • 55. [AIDS--a disease we must be prepared to treat].
    Mutschler E; Dingermann T
    Pharm Unserer Zeit; 2001; 30(3):181. PubMed ID: 11400659
    [No Abstract]   [Full Text] [Related]  

  • 56. Is G8 putting profits before the world's poorest children?
    Light DW
    Lancet; 2007 Jul; 370(9584):297-8. PubMed ID: 17662863
    [No Abstract]   [Full Text] [Related]  

  • 57. Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
    Santos AF; Abecasis AB; Vandamme AM; Camacho RJ; Soares MA
    J Antimicrob Chemother; 2009 Mar; 63(3):593-9. PubMed ID: 19136678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV protease as an inhibitor target for the treatment of AIDS.
    Darke PL; Huff JR
    Adv Pharmacol; 1994; 25():399-454. PubMed ID: 8204507
    [No Abstract]   [Full Text] [Related]  

  • 59. AIDS from vaccine?
    Science; 1995 Aug; 269(5224):639. PubMed ID: 7624791
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV-1 protease inhibitors: development, status, and potential role in the treatment of AIDS.
    Lang M; Roesel J
    Arch Pharm (Weinheim); 1993 Dec; 326(12):921-4. PubMed ID: 8122962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.